Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This study (Unique Protocol ID: ZGJAK020) as an extension of the ongoing "Study to Evaluate
Safety and Efficacy of Jaktinib in Adults With Alopecia Areata (Unique Protocol ID:ZGJAK020)"
study. After completion of ZGJAK018 study, the study will be directly extend with an
"open-label design".